Drug combo shows promise for weight loss in severe obesity
NCT ID NCT03968224
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether adding dapagliflozin to metformin helps people with prediabetes or type 2 diabetes and severe obesity lose more weight than metformin alone. About 160 participants took either both drugs or just metformin for up to 12 months. The main goal was to see if the combination leads to at least 10% more weight loss. The study also checked changes in blood pressure and waist size.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital de Especialidades Centro Médico Nacional Siglo XXI
Mexico City, 06720, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new rice could tame blood sugar spikes in prediabetes
- Can Weight-Loss surgery change how medications work?
- Can stomach surgery alter how painkillers work?
- Can Weight-Loss surgery change how medications work?
- Can Weight-Loss surgery change how medicines work?
- Can Weight-Loss surgery change how blood pressure drugs work?